BIOMAT Database Logo BIOMAT Database Logo

[Study of the effect of adenosine cyclic 3'-5'-monophosphate (3'-5'-AMPc) and cyclic 3'-5'-phosphodiesterase (3'-5'-FDEc) on the adipose tissue of normal, diabetic and obese patients]. 1972

M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase.
November 1970, The Biochemical journal,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Adenosine 3',5'cyclic monophosphate in adipose tissue of diabetic rats.
December 1976, Biochimica et biophysica acta,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Effect of reductones on cyclic 3', 5'-adenosine monophosphate phosphodiesterase.
January 1985, Acta vitaminologica et enzymologica,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
An effect of insulin on the adenosine 3':5'-cyclic monophosphate phosphodiesterase and guanosine 3':5'-cyclic monophosphate phosphodiesterase activities in the perfused Langendorff and working hearts of normal and diabetic rats.
July 1972, The Biochemical journal,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia.
January 1986, Haematologia,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
January 1973, Biochemical pharmacology,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Lipolysis and adenosine 3',5'-cyclic monophosphate in adipose tissue of the New Zealand obese mouse.
January 1973, The Journal of endocrinology,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase.
December 1970, The Biochemical journal,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
3':5'-cyclic adenosine monophosphate phosphodiesterase: negative cooperativity.
July 1972, Proceedings of the National Academy of Sciences of the United States of America,
M A Yáñez Polo, and F C Soriguer Escofet, and E Lissen Otero, and M Causse Prado, and R Perez Cano, and M Melero Bellido, and J Muñóz-González
Reduced adenosine 3',5'-monophosphate phosphodiesterase activity in the pancreas and adipose tissue of spontaneously diabetic mice.
June 1969, Life sciences,
Copied contents to your clipboard!